Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Calgary Doctor Claims Generic Ozempic and Wegovy Drugs May Cut Costs by One-Third - Featured image
Health

Calgary Doctor Claims Generic Ozempic and Wegovy Drugs May Cut Costs by One-Third

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·January 14, 2026·1 min read

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

According to a Calgary doctor, affordable generic alternatives to drugs like Ozempic and Wegovy might reduce expenses by up to a third. The content explores regional approaches to obesity management in Canada, emphasizing the challenges of rewiring brain circuitry and the role of medications in promoting healthier eating habits.

Share

For instance, in Quebec, weight-related issues are frequently seen as the individual's own burden, with treatment primarily emphasizing behavioral adjustments instead of relying on medical treatments. In Alberta, Lau explained that it involves a blend of approaches, tailored to each individual's needs.

'Individuals who become overweight or obese,' he noted, 'have their neural pathways altered so that they persistently desire additional sustenance, especially items high in sugar or fats. Consequently, modifying these pathways proves exceedingly difficult without supporting long-term adoption of nutritious dietary patterns. This is precisely where GLP-1 drugs, among other therapies, prove invaluable, as they aid in reducing both the quantity and type of consumed foods.'

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Health tracking tools such as Shotlee can support individuals in overseeing their dietary shifts and overall progress.

Source Information

Originally published by Calgary Herald.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Ozempic and Male Fertility: Can Semaglutide Boost Sperm Quality?
Health & Wellness

Ozempic and Male Fertility: Can Semaglutide Boost Sperm Quality?

Emerging research indicates that GLP-1 medications, including Ozempic and Mounjaro, may offer unexpected benefits for male reproductive health by addressing underlying metabolic issues.

7 min read
Semaglutide and Male Fertility: New Study Reveals Testosterone Boost
Health & Wellness

Semaglutide and Male Fertility: New Study Reveals Testosterone Boost

Can GLP-1 medications like Ozempic or Wegovy improve male fertility? A new study indicates potential benefits for testosterone and sperm health, but what does this mean for patients?

7 min read
Semaglutide and Blood Pressure Meds: Why Dizziness Risk Is Rising
Health & Wellness

Semaglutide and Blood Pressure Meds: Why Dizziness Risk Is Rising

A new study reveals a potential safety concern when combining GLP-1 medications with blood pressure drugs, highlighting the importance of monitoring hypotensive episodes in select patients.

8 min read

Same topic: Obesity Management

All Obesity Management articles →
Beyond Willpower: Understanding Obesity's Metabolic Roots
Health & Wellness

Beyond Willpower: Understanding Obesity's Metabolic Roots

Obesity is a complex, multi-organ disease, not a failure of willpower. This article delves into its metabolic underpinnings and outlines a practical approach to management, including modern medications and lifestyle adjustments.

7 min read
Survodutide Shines: Dual GLP-1/Glucagon Agonist Shows Major Weight Loss
Pharmaceutical News & Drug Development

Survodutide Shines: Dual GLP-1/Glucagon Agonist Shows Major Weight Loss

Zealand Pharma and Boehringer Ingelheim announced breakthrough Phase 3 results for survodutide, a dual GLP-1 and glucagon receptor agonist, demonstrating significant weight reduction and metabolic improvements in adults with obesity or overweight.

7 min read
Duodenal Resurfacing: A New Hope Beyond GLP-1 Weight Loss?
Weight Management

Duodenal Resurfacing: A New Hope Beyond GLP-1 Weight Loss?

The emergence of GLP-1 receptor agonists has revolutionized obesity treatment, but concerns about weight regain upon discontinuation are significant. New research on duodenal mucosal resurfacing suggests a potential breakthrough in maintaining weight loss long-term.

7 min read

More in Health

Pfizer's Berobenatide: A New Monthly GLP-1 for Weight Loss?
Health & Wellness

Pfizer's Berobenatide: A New Monthly GLP-1 for Weight Loss?

Pfizer's investigational GLP-1 receptor agonist, berobenatide, has shown promising results in Phase 2b trials for weight loss. This article delves into the data, its implications for obesity treatment, and what it means for Pfizer's investment outlook.

7 min read
Wegovy Pill Arrives in the UK: A New Era for Weight Management?
Health & Wellness

Wegovy Pill Arrives in the UK: A New Era for Weight Management?

The UK has officially approved a pill version of the popular Wegovy weight-loss drug, marking a significant advancement in accessible obesity treatment. This development offers a convenient alternative to weekly injections for many.

6 min read
Beyond Ozempic: The Future of Weight Loss & Metabolic Health Innovation
Health & Wellness

Beyond Ozempic: The Future of Weight Loss & Metabolic Health Innovation

The GLP-1 revolution is just the beginning. This article delves into the cutting-edge advancements poised to reshape the future of weight loss and metabolic health, offering insights for patients and observers alike.

7 min read
Share this article
  1. Home
  2. Blog
  3. Calgary Doctor Claims Generic Ozempic and Wegovy Drugs May Cut Costs by One-Third
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community